Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Papillomavirus Infections 1Hepatitis C, Chronic 1Fibrosis 1Condylomata Acuminata 1Carcinoma, Hepatocellular 1

Interventions

Tenofovir 2Sorafenib 2Low-Level Light Therapy 2High-Energy Shock Waves 2sonidegib 1ruxolitinib 1navitoclax 1hepatitis B hyperimmune globulin 1bavituximab 1adefovir dipivoxil 1Viusid 1Vitamin E 1Restraint, Physical 1Physical Therapy Modalities 1Pentoxifylline 1Magnetic Resonance Spectroscopy 1Liver Transplantation 1Lamivudine 1Independent Medical Evaluation 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Enkephalin, Methionine 1Dietary Supplements 1Clinical Trials as Topic 1Breath Tests 1Blood Specimen Collection 1Angptl4 protein, mouse 1Albumin-Bound Paclitaxel 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fibrosis × Viusid × Clear all
NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Catalysis SL

Phase 3 Completed
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡